KIF2A and gastric cancer: To further validate this possibility, we conducted a study on the effect of KIF2A on chemosensitivity of GC cells, which discovered that knockdown of KIF2A improved the chemosensitivity to oxaliplatin largely and only increased that to capecitabine mildly in GC cell lines.